[HTML][HTML] 基于靶点的抗新型冠状病毒病COVID-19 药物发现
刘艾林， 杜冠华 - 药学学报, 2020 - html.rhhz.net
… -2 replication and pathogenesis will provide a more effective means for clinical treatment. In
… New approaches to drug discovery for COVID-19 treatment using molecular simulation and …
… New approaches to drug discovery for COVID-19 treatment using molecular simulation and …
[HTML][HTML] 新型冠状病毒肺炎治疗药物的研究现状及对策建议
邹全明， 李海波， 曾浩 - 2020 - aammt.tmmu.edu.cn
… of novel coronavirus-infected pneumonia and treatment protocols which have been shown
to … Treatment of severe acute respiratory syndrome with convalescent plasma[J]. Hong Kong …
to … Treatment of severe acute respiratory syndrome with convalescent plasma[J]. Hong Kong …
[HTML][HTML] Efficacy of Zhumian Tang formula granules (助眠汤配方颗粒) combined with eszopiclone for the treatment of poor sleep quality: a multi-center, randomized …
W Yichen, WU Shiyi, W Zhengyan… - Journal of Traditional …, 2024 - ncbi.nlm.nih.gov
… eszopiclone treatment group, the PSQI score of the combined treatment … of the combined
treatment group remained significantly … Because of the coronavirus-19 epidemic, the study was …
treatment group remained significantly … Because of the coronavirus-19 epidemic, the study was …
新型冠状病毒感染对哮喘儿童肺功能影响
王金荣， 苗瑜， 光增， 曹洛菲 - 临床儿科杂志, 2023 - jcp.xinhuamed.com.cn
… 严重急性呼吸综合征冠状病毒2 (severe acute respiratory syndrome coronavirus 2,SARS-CoV…
Eosinopenia is associated with greater severity in patients with coronavirus disease 2019 [J]…
Eosinopenia is associated with greater severity in patients with coronavirus disease 2019 [J]…
[HTML][HTML] “长新冠” 的多系统症状及机制研究进展
廖雪姣， 吴舒婷， 马拯华， 卢洪洲 - 2023 - jmi.fudan.edu.cn
: 严重急性呼吸综合征冠状病毒2 (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2)
及其变异毒株引发的疫情给全球的公共卫生安全带来了极大的挑战. 尽管现阶段各国已进入…
及其变异毒株引发的疫情给全球的公共卫生安全带来了极大的挑战. 尽管现阶段各国已进入…
[PDF][PDF] 补充维生素D 在新型冠状病毒肺炎辅助治疗中的作用研究进展
雷艳， 詹世淮， 施小华， 王水良， 赵猛， 张胜行 - 新医学, 2022 - xinyixue.cn
新型冠状病毒肺炎(COVID-19) 引起的大流行给全球公共卫生健康带来了严峻的挑战. 维生素D
作为免疫调节剂, 在增强免疫, 抗呼吸道病毒感染方面具有重要作用. 研究表明维生素D 可通过…
作为免疫调节剂, 在增强免疫, 抗呼吸道病毒感染方面具有重要作用. 研究表明维生素D 可通过…
[HTML][HTML] 2019 新型冠状病毒肺炎（ COVID-19） 对溶血性疾病发生、 发展与治疗的影响
王朝， 赵玉平 - Chinese Journal of Hematology, 2020 - ncbi.nlm.nih.gov
… Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19)
infections and deaths?[J] Pathog Glob Health. 2020;114(3):109–110. …
infections and deaths?[J] Pathog Glob Health. 2020;114(3):109–110. …
[PDF][PDF] 新型冠状病毒与严重急性呼吸综合征冠状病毒的比较认知
祝坤杰， 喻建军 - 国际流行病学传染病学杂志, 2020 - gl.hmc.edu.cn
… The review about preliminary work of SARS diagnosis and treatment is of great signifir …
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China [J]. …
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China [J]. …
[PDF][PDF] 抗新型冠状病毒靶点及药物研究进展
韩露， 王同兴， 肖智勇， 周文霞… - 中国药理学与毒理学 …, 2020 - cjpt.magtechjournal.com
… Development of a standard treatment protocol for severe acute respira⁃ tory syndrome[J]. …
How to reduce the likelihood of coronavirus-19(CoV-19 or SARSCoV-2)infection and lung …
How to reduce the likelihood of coronavirus-19(CoV-19 or SARSCoV-2)infection and lung …
[HTML][HTML] 铜绿假单胞菌对TLR4 缺失鼠的致病性研究
白江松， 张子卉， 连朋敬， 奚柳青， 李静云， 徐彤… - 畜牧兽医学报, 2022 - xml-data.org
… Abstract: This study aims to understand the role of TLR4 signal transduction in the pathogenesis
of … In summary, the lack of TLR4 protein significantly increased the pathogenicity of …
of … In summary, the lack of TLR4 protein significantly increased the pathogenicity of …